Brief: Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology
12/05/2026 06:00
May 12 (Reuters) - ROCHE HOLDING AG ROPC.S: RECEIVES CE MARK FOR NEW BLOOD TEST TO DETECT ALZHEIMER'S PATHOLOGY Further company coverage: ROPC.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on Roche Holding AG
See all newsBrief: Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology
Analysis: TrumpRx lists many medicines at prices higher than paid in UK
Brief: Mankind Pharma Buys Rivotril Brand From Roche For India
Brief: Novartis to spend extra $200 mln to push Entresto - CEO
Novartis willing to sell Roche stake without demanding premium - CEO (updated)